Each single time you turn in your television, open a paper or magazine as well as tune in to the radio you happen to be bound to listen to about people having sleeplessness. The issue - most of the info is coming from pharmaceutical and biotech firms decided to take advantage of the sleepless masses.
The marketplace for eszopiclone generic drugs in the U.S. reached $4.6 billion in 2006 alone. No wonder many pharmaceutical companies are treating this happening as the "new gold rush". These firms come in a race to gain market share.
How large is this market?
An estimated 30-50% of the overall public is affected by insomnia. According to the National Institute of Health, more than 70 million Americans experience sleeplessness. Yet, just 15% seek treatment for their sleeplessness. The main reason a lot of people refuse to take sleeplessness drugs are because of the negative effects.
A few of the unwanted effects include:
o Substance addiction
o Withdrawal symptoms
o Physical side effects
o Serious interactions with other drugs or substances in the body
Since the pharmaceutical companies recognize they possess the medical profession behind them the promotion has reached an all-time high. It's clear that the medical profession would concur that sleeplessness is an issue. They consider treating sleeplessness is vital because a lack of sleep often leads to serious illnesses.